Study Summary
This trial is designed to increase the effectiveness of an existing emergency department "bridge" program for opioid use disorder by adding contingency management to the program.
- Opioid Use Disorder
Treatment Effectiveness
Effectiveness Progress
Study Objectives
4 Primary · 4 Secondary · Reporting Duration: 3-months
Trial Safety
Trial Design
2 Treatment Groups
Standard Care
1 of 2
Contingency Management
1 of 2
Active Control
Experimental Treatment
100 Total Participants · 2 Treatment Groups
Primary Treatment: Contingency management · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
Washington | 100.0% |
How old are they?
18 - 65 | 100.0% |
What portion of applicants met pre-screening criteria?
Did not meet criteria | 100.0% |
Frequently Asked Questions
Are there any vacancies for subjects to join this research experiment?
"Affirmative. The information found on clinicaltrials.gov indicates that this trial is recruiting participants as of now. This experiment was first made available to the public on January 27th 2020 and has been edited most recently on November 23rd 2021. It requires a total of 100 volunteers from one medical site for completion." - Anonymous Online Contributor
What is the overall enrollment for this clinical research project?
"Yes, according to clinicaltrials.gov, the trial is currently seeking participants with a post date of January 27th 2020 and an edit date of November 23rd 2021. 100 individuals will be enrolled across one site." - Anonymous Online Contributor
What are the main aims of this medical experiment?
"This 3-month trial will measure patient Attendance at first scheduled clinic appointment as its primary outcome. Secondary endpoints include an evaluation of Opioid demand correlated with drug test results for opioid abstinence and buprenorphine adherence, a drawing task to assess Neurological Soft Signs associated with successful treatment, and Substance-free activities linked to urine tests measuring opioid abstention and buprenorphine compliance." - Anonymous Online Contributor